Comparison of TBM and non-TBM cases identified CSF immunological analytes, namely IL-1β, IL-17, PDGF-BB, G-CSF and cathelicidin that were significantly elevated in the TBM compared to non-TBM patients. This evidence concerns the gene IL1B and meningeal tuberculosis.